vimarsana.com

Page 239 - தொழில் முனைவோர் மகேந்திரா நாத் பாண்டே News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kidscreen » Archive » APC Kids inks broadcast deals for DinoCity

APC Kids is readying new series DinoCity for screens with a number of international sales. The preschool show is produced by Riki Group in partnership with Animax Production animation studio. Piwi+ (France) and MBC (MENA) picked up pay TV rights for the 2D-animated series, while ERT (Greece) and Ketnet (Belgium) secured free TV rights. Additionally, Menart (Slovenia, Croatia, Bosnia, Herzegovina, Macedonia) licensed exclusive free TV rights and non-exclusive SVOD rights for DinoCity. The 52 x five-minute adventure toon, set to premiere this month, follows a family of dinosaurs living in a modern city. APC Kids has already pre-sold the series to broadcasters including DeA Kids (Italy), YLE (Finland) and Canal+ (Poland).

ZipRecruiter s New Act Fast! Alert Helps Businesses Secure Top Candidates

Germany s BDI industry body hikes forecast for 2021 export growth

Phase 3 Prevention Trial Showed 81% Reduced Risk of Symptomatic SARS-CoV-2 Infections with Subcutaneous Administration of REGEN-COV™ (casirivimab with imdevimab)

Published: Apr 12, 2021 TARRYTOWN, N.Y., April 12, 2021 /PRNewswire/ REGEN-COV rapidly protected household contacts from exposure to SARS-CoV-2 at home, with 72% protection against symptomatic infections in the first week, and 93% in subsequent weeks Among individuals who developed symptomatic infections, REGEN-COV recipients cleared the virus faster and had much shorter symptom duration Regeneron will share data with U.S. FDA and request EUA expansion to include COVID prevention for appropriate populations, using a 1,200 mg subcutaneous dose Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive results from a Phase 3 trial (2069A) assessing the ability of REGEN-COV™ (casirivimab with imdevimab) to reduce the risk and burden of COVID-19 infection among household contacts of SARS-CoV-2 infected individuals. The trial, which was jointly run with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (

Honey summit to end sticky manuka troubles with New Zealand

Hopes a manuka honey summit between Australia and New Zealand could end sticky trademark situation Posted Yesterday at 5:56pm MonMonday 12 updated Yesterday at 11:44pm MonMonday 12 AprApril 2021 at 11:44pm A honey bee pollinates the flower of New Zealand tea tree variety Leptospermum scoparium, which makes Manuka honey. ( Print text only Cancel The federal government wants Australian and New Zealand beekeepers to hold a workshop to end a long-running trans-Tasman battle over manuka honey. Key points: Manuka honey is made from the nectar of Leptospermum trees, which are native to Australia and New Zealand NZ producers have attempted to trademark the term in at least seven jurisdictions

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.